Replies to post #6228 on Aurinia Pharmaceuticals Inc (AUPH)

[tiv111]

I don't see why anybody would blame the CEO for the the timing of their buy and sells. Everyone had the same opportunity to buy low before the P2 results (like I did) and sell at the high of $10+ (like I didn't, but could have).
The dilution was needed and certainly the best of all possible options for moving the company through P3 results.
Didn't see the Cramer segment but in my opinion the CEO has kept us well informed about what we own. I feel like I know exactly where we stand moving forward. Can't say that about many of my other investments.